Month: July 2020

FDA Approves Tecartus (brexucabtagene autoleucel) as the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma Print this page SANTA MONICA, Calif.–(BUSINESS WIRE)–Jul. 24, 2020– Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tecartus™ (brexucabtagene autoleucel, formerly KTE-X19), the first and only
0 Comments
Over-the-counter (OTC) analgesics like acetaminophen, ibuprofen, and acetylsalicylic acid (aspirin) have long been a staple in households for managing pain, fevers, and other common ailments. However, the accessibility of these medications can make them easy to take in dangerous amounts. In a new study, researchers at the Center for Injury Research and Policy and the
0 Comments
Flu and pneumonia vaccinations were linked to reduced risk of Alzheimer’s disease, research from the virtual Alzheimer’s Association International Conference (AAIC) suggested. People who were vaccinated against pneumonia when they were ages 65 to 75 years had nearly 40% less risk of Alzheimer’s disease depending on their genetic profile, reported Svetlana Ukraintseva, PhD, of Duke
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. From mid-March to mid-May, heart donor recoveries and heart transplant volume both decreased by 26% nationally, compared with the early part of 2020. COVID-19’s greatest impact on heart transplant activity was seen in the hardest-hit Northeast part of the country, but
0 Comments
The easiest way to prepare asparagus is to roast them. Just toss them in with oil and seasoning and bake it for a few minutes, and you have a crispy side dish for your chicken or pork dishes. This quick method of preparation always works well, even if you just use salt and pepper to
0 Comments
Print this page SAN DIEGO, CA and TAICANG, SUZHOU, China – July 20, 2020 – Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating molecules today announced that the first patient has been dosed in a Phase 2 clinical trial of CBP-201 for the treatment of moderate-to-severe atopic
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today: New Symptom Oral petechial lesions observed in a small number of COVID-19 patients have some dermatologists curious if enanthem, in addition to skin rash
0 Comments
Welcome to Harvard Medical School, where a vibrant community is shaping the future of education and biomedicine. This is a place where bold ideas are incubated, a place where extraordinary individuals working as teams tackle tough problems with unrelenting passion. In the past year alone, the school has moved in exciting new directions, propelled by
0 Comments
Our bodies are very good at fighting infections. The immune system reacts and attacks the bacteria and viruses that make us sick. But sometimes the immune reaction is so strong that it damages the body too. This is called a septic reaction, or sepsis. And the mortality rate associated with it can be high. Doctors
0 Comments
He’s known to millions as ‘The Body Coach’, and he’s possibly the most famous PE teacher in the world, but it’s the titles of ‘dad’ and ‘husband’ that Joe Wicks loves the most This is a preview of the full interview, available in Happiful Magazine August 2020. To read the full version, buy in print
0 Comments
The US Food and Drug Administration (FDA) today granted accelerated approval to brexucabtagene autoleucel (Tecartus, Kite Pharma), the first approved chimeric antigen receptor (CAR) T cell therapy for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). The new agent is the second approved CAR T cell product developed by Kite and follows
0 Comments
As more of us than ever are working remotely, it’s natural to miss those social moments with colleagues by the water cooler. But technology is here to help… The sound of my ringtone gives me anxiety. Who dares to call ‘just to talk’? What’s wrong with a text? Or a handwritten letter? Anything – and
0 Comments
There’s no harm in admitting it: Many of us have been a little restless (maybe even more than a little) during the pandemic, and the changes it brought into our lives, with daily schedules that can either make us sleep more than usual or barely at all. However, while it’s crucial to try and keep a consistent
0 Comments
Medical professionals are tweeting pictures of themselves in swimsuits with the hashtag #MedBikini, accompanied by sharp rebukes of a study that labeled such images on social media as “potentially unprofessional.”  The study, published by researchers at Boston University School of Medicine in the Journal of Vascular Surgery, sought to quantify the prevalence of “unprofessional” content
0 Comments
FDA Approves Wynzora Cream (calcipotriene and betamethasone dipropionate) for Adults with Plaque Psoriasis Print this page COPENHAGEN, Denmark, July 22, 2020 / B3C newswire / — MC2 Therapeutics, a commercial stage pharmaceutical company developing a new standard of topical therapies for chronic inflammatory conditions, announced today that the U.S. Food and Drug Administration (FDA) has
0 Comments